185 related articles for article (PubMed ID: 9733391)
1. Glycopeptide-induced vasculitis--cross-reactivity between vancomycin and teicoplanin.
Marshall C; Street A; Galbraith K
J Infect; 1998 Jul; 37(1):82-3. PubMed ID: 9733391
[TBL] [Abstract][Full Text] [Related]
2. [The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci].
Pham Dang C; Gouin F; Touchais S; Richard C; Potel G
Pathol Biol (Paris); 2001 Sep; 49(7):587-96. PubMed ID: 11642024
[TBL] [Abstract][Full Text] [Related]
3. A closer look at vancomycin, teicoplanin, and antimicrobial resistance.
Zeckel ML
J Chemother; 1997 Oct; 9(5):311-31; discussion 332-5. PubMed ID: 9373787
[TBL] [Abstract][Full Text] [Related]
4. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
Huang JH; Hsu RB
Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
Hung YP; Lee NY; Chang CM; Lee HC; Wu CJ; Chen PL; Lee CC; Chung CH; Ko WC
Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
[TBL] [Abstract][Full Text] [Related]
6. Comparative safety of teicoplanin and vancomycin.
Wilson AP
Int J Antimicrob Agents; 1998 May; 10(2):143-52. PubMed ID: 9716291
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin-induced neutropenia resolves after substitution with teicoplanin.
Sanche SE; Dust WN; Shevchuk YM
Clin Infect Dis; 2000 Sep; 31(3):824-5. PubMed ID: 11017842
[TBL] [Abstract][Full Text] [Related]
8. Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin.
Hsiao SH; Chang CM; Tsai JC; Lin CY; Liao LH; Lin WL; Wu TJ
Ann Pharmacother; 2007 May; 41(5):891-4. PubMed ID: 17426073
[TBL] [Abstract][Full Text] [Related]
9. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Shen WC; Chiang YC; Chen HY; Chen TH; Yu FL; Tang CH; Sue YM
Nephrology (Carlton); 2011 Nov; 16(8):697-703. PubMed ID: 21707841
[TBL] [Abstract][Full Text] [Related]
10. Teicoplanin-induced vasculitis with cutaneous and renal involvement.
Logan SA; Brown M; Davidson RN
J Infect; 2005 Oct; 51(3):e185-6. PubMed ID: 16230204
[TBL] [Abstract][Full Text] [Related]
11. Teicoplanin versus vancomycin for proven or suspected infection.
Cavalcanti AB; Goncalves AR; Almeida CS; Bugano DD; Silva E
Cochrane Database Syst Rev; 2010 Jun; (6):CD007022. PubMed ID: 20556772
[TBL] [Abstract][Full Text] [Related]
12. The use and therapeutic drug monitoring of teicoplanin in the UK.
Darley ES; MacGowan AP
Clin Microbiol Infect; 2004 Jan; 10(1):62-9. PubMed ID: 14706088
[TBL] [Abstract][Full Text] [Related]
13. Vertebral osteomyelitis caused by vancomycin-tolerant methicillin-resistant Staphylococcus aureus bacteremia: Experience with teicoplanin plus fosfomycin combination therapy.
Lee WS; Chen YC; Chen HP; Chen TH; Cheng CY
J Microbiol Immunol Infect; 2016 Aug; 49(4):600-3. PubMed ID: 24269007
[TBL] [Abstract][Full Text] [Related]
14. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
[TBL] [Abstract][Full Text] [Related]
15. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
[TBL] [Abstract][Full Text] [Related]
17. Allergic cross-reactivity of teicoplanin and vancomycin.
McElrath MJ; Goldberg D; Neu HC
Lancet; 1986 Jan; 1(8471):47. PubMed ID: 2867290
[No Abstract] [Full Text] [Related]
18. Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review.
Hsiao SH; Chen HH; Chou CH; Lin WL; Liu Yeh PY; Wu TJ
J Clin Pharm Ther; 2010 Dec; 35(6):729-32. PubMed ID: 21054466
[TBL] [Abstract][Full Text] [Related]
19. A four-year-old child with teicoplanin allergy but no evidence of cross-reaction with vancomycin.
de Vries E; van Weel-Sipman MH; Vossen JM
Pediatr Infect Dis J; 1994 Feb; 13(2):167. PubMed ID: 8190551
[No Abstract] [Full Text] [Related]
20. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
Van Laethem Y; Hermans P; De Wit S; Goosens H; Clumeck N
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]